San West Inc. (OTCBB: SNWT) is primed for a bounce this morning on news that the company logged $150K in Internet sales ALONE between 11/18 and 12/17. After finding strong support around $.22 for a number of weeks, the stock has slid recently, closing Tuesday at $.132. With positive corporate announcements in consecutive days, SNWT is poised for a big day in the market on Wednesday. (more…)

As some readers have mentioned recently, Echo Therapeutics, Inc. (OTCBB: ECTE) is showing a great deal of promise to surpass many of its competitors over the next 12 to 24 months, both with regard to market penetration, sales, and PPS. DexCom, Inc. (NASDAQ: DXCM) is trading at nearly $8 per share despite logging only $9.8M in 2008 revenues and annual net income of ($55.2M). While the company’s “SEVEN” CGM product is FDA-approved, Echo’s “Symphony” system is stronger in many regards.

(more…)

Elysium Internet, Inc. (OTCPK: EYSM) rose for a 4th straight day on Thursday bringing the week’s total gains to $.026 or 137%. Trading volume for the past 12 sessions is about 64,000,000 shares, representing a 1063% increase over the prior 12-day period. After gaining another 13% today, ESYM made a post-market announcement that it is entering the $7 billion Chiropractic marketplace with its recent acquisition of  www.Chiropractor.net

EYSM: 5-day Chart

(more…)

It looks like we hit the nail on the head with our breakout call for Elysium Internet Inc. (OTCPK: EYSM) earlier in the week. After rising roughly 85% during the first two days of the week, EYSM gained 12.1% or $.0043 Wednesday on more than 8.5 million shares traded. Volume this week has been explosive and today’s news drove the stock higher as we stated it might in yesterday’s commentary.

(more…)

Echo Therapeutics, Inc. (OTCBB: ECTE) moved higher on Wednesday, gaining 1.45% or $.02 on 42,950 shares traded. While the recent trading activity has been intriguing, the future potential of the company is what really has us hooked. As mentioned in yesterday’s analyst report, Echo is positioned to dominate the global diabetic monitoring marketplace with its revolutionary needle-free system. The company also has a multitude of additional opportunities at its fingertips.

(more…)

Echo Therapeutics is a transdermal medical device and specialty pharmaceuticals company. Echo’s Symphony™ tCGM System is a non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (tCGM) system focused on changing the paradigm of invasive, episodic glucose testing in diabetes home use and hospital critical care markets.

Echo’s AzoneTS™ transdermal drug reformulation technology is focused on building a pipeline of safer and improved versions of widely-prescribed, FDA-approved specialty pharmaceutical products. Echo is developing most of its AzoneTS pipeline in accordance with the FDA’s Section 505(b)(2) guidelines. Durhalieve™, Echo’s lead AzoneTS drug candidate, is an advanced topical reformulation of triamcinolone acetonide for treatment of corticosteroid responsive dermatoses. Echo has submitted its Durhalieve New Drug Application (NDA) to the FDA.

San West, Inc. (OTCBB: SNWT)  designs, manufactures, sells and repairs off-road buggies, and additionally provides aftermarket performance products and accessories for off-road buggies. Products are sold via three divisions: at retail store locations, via the online store and through its growing dealer network. Buggy repair services are sold and fulfilled at the Santee, California retail location. For further information about San West Inc. visit www.CountyImports.com, www.BuggyWorld.net, www.CountyImportParts.com and www.SanWestInc.com.

Echo Therapeutics, Inc. (OTCBB: ECTE) gained 9.6% or $.12 today on nearly 98,000 shares traded after analyst firm Boenning & Scattergood issued an “outperform” rating on the company along with a 12-month price target of $3.

(more…)

Since our Monday morning alert, Elysium Internet (OTCPK: EYSM) has gained more than 84% on roughly 9.1 million shares traded. The move from $.019 to $.035 has been driven by a 304% 2-day volume increase and is showing no signs of subsiding.

(more…)

After gaining more than 2% on nearly 576,000 thousand shares traded, San West Inc. (OTCBB: SNWT) announced a strategic move at market close on Monday that holds the potential to generate significant sales and profit growth for the company immediately. (more…)